Abiopharma

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

PULSENMORE (PLSM) was added to the list of traded instruments on TASE exchange

New Form SCHEDULE 13G - Biodexa Pharmaceuticals Plc Filed: 2026-01-20 AccNo: 0001535610-26-000008 Size: 9 KB

New Form 3 - AKANDA CORP. Filed: 2026-01-20 AccNo: 0001475597-26-000001 Size: 3 KB

New Form SCHEDULE 13G/A - Pennant Group, Inc. Filed: 2026-01-20 AccNo: 0001524408-26-000002 Size: 20 KB

Waters - Waters Corporation Schedules Fourth Quarter 2025 Earnings Conference Call

Waters Corporation Schedules Fourth Quarter 2025 Earnings Conference Call

Mentorship Matters: How to Build a STEM Network That Lifts You Up

Shareholder Alert: The Ademi Firm investigates whether RAPT Therapeutics, Inc. is obtaining a Fair Price for its Public Shareholders

Kick off 2026 with CAHPS Insider Live

Tiziana Life Sciences Ltd. (TLSA) Files Form 6-K

New Form SCHEDULE 13G/A - MAINZ BIOMED N.V. Filed: 2026-01-20 AccNo: 0002105585-26-000006 Size: 5 KB

New Form DEF 14A - Healthcare Triangle, Inc. Filed: 2026-01-20 AccNo: 0001213900-26-005400 Size: 1 MB

New Form 4/A - MAINZ BIOMED N.V. Filed: 2026-01-20 AccNo: 0002105585-26-000005 Size: 4 KB